CCL5 immunoreactivity was correlated with the aggressive phenotype of breast carcinomas only in the CCR3-positive group, and we speculated that the CCL5-CCR3 interaction might have important role in tumor progression. This evidence concerns the gene CCL5 and breast carcinoma.